Description
Tesamorelin is a stabilized GHRH analogue studied in growth hormone release, IGF-1 response, and metabolic-signalling research. It is commonly discussed in relation to visceral fat and endocrine pathway models because it stimulates the GHRH receptor rather than acting as growth hormone itself.
Molecular Profile
Molecular Weight: ~5,136 Da
Purity: Per batch COA
Format: Lyophilized white powder
Storage: -20°C, desiccated
Reconstitution: Sterile bacteriostatic water
Research Context
Tesamorelin has generated significant interest in metabolic and endocrine signalling research due to its activity as a GHRH receptor agonist. Scientific literature documents its use in studying growth hormone release, IGF-1 modulation, visceral adipose tissue biology, glucose metabolism, and age-related endocrine pathway models. Research teams use GHRH analogues such as Tesamorelin to evaluate receptor-mediated signalling cascades and their downstream effects on metabolic regulation.
Quality Assurance
Each batch is independently tested for purity, identity, and quality before release. A Certificate of Analysis is available for every lot. All compounds are produced under strict quality control conditions and shipped under appropriate handling protocols from within Canada.
